
|Articles|July 1, 1998
Supplements and Featured Publications
- New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
- Volume 4
- Issue 7 Suppl
Exploring the Benefits Beyond Blood Pressure Control
Author(s)Hans Lithell, MD, Luis Ruilope, MD
Advertisement
Articles in this issue
almost 28 years ago
Participating Facultyalmost 28 years ago
Gene Polymorphism Influences Response to Angiotensin Blockadealmost 28 years ago
New Drug Class Offers Benefits in Heart Failurealmost 28 years ago
What are the Pharmacological Differences Between Angiotensin II Antagonistsalmost 28 years ago
Clinical Implications of Differences Between Angiotensin II AntagonistsAdvertisement
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
4
Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered
5




